BioLargo’s PFAS treatment technology generates a fraction of the waste compared to carbon filtration
In the EPA
press release, EPA Administrator Michael S. Regan stated, “Designating
these chemicals under our Superfund authority will allow EPA to address more
contaminated sites, take earlier action, and expedite cleanups, all while
ensuring polluters pay for the costs to clean up pollution threatening the
health of communities.” These new regulations come on the heels of the EPA’s
announcement two weeks ago setting PFAS drinking water limits as low as four parts
per trillion.
This new EPA action also means that these PFAS chemicals
will be listed as “hazardous materials” under the Hazardous Materials
Transportation Act, which will require materials containing these chemicals to
be transported using special protocols.
Tonya Chandler, President of BioLargo Equipment Solutions
& Technologies, Inc., which markets BioLargo’s PFAS treatment systems,
commented, “We believe these and other upcoming regulations create a price
advantage for our AEC system over competing sorbent technologies such as carbon
filtration. With less waste generated, we can also offer clients waste handling
all the way through to full destruction at our facility.”
These finalized CERCLA regulations are the most recent step
by the EPA to limit exposure of Americans to PFAS. In addition to the recently
announced federal drinking water standards for six PFAS chemicals, the agency
also committed $9 billion in funding to help communities and water providers
address contamination by PFAS and other emerging contaminants. This funding
will assist communities and water providers to acquire PFAS monitoring and
treatment systems to comply with new regulations.
Dennis P. Calvert, President and CEO of BioLargo, commented,
“We’re pleased to see the U.S. government taking PFAS seriously and dedicating
the billions of dollars in funding needed to protect municipal water supplies
across the country.”
About BioLargo, Inc.
BioLargo, Inc. (OTCQB:BLGO) is a cleantech and life sciences
innovator and engineering services solution provider. Our core products address
PFAS contamination, achieve advanced water and wastewater treatment, control
odor and VOCs, improve air quality, enable energy-efficiency and safe on-site
energy storage, and control infections and infectious disease. Our approach is
to invent or acquire novel technologies, develop them into product offerings,
and extend their commercial reach through licensing and channel partnerships to
maximize their impact. See our website at www.BioLargo.com.
About BioLargo Equipment Solutions & Technologies
BioLargo Equipment Solutions & Technologies, Inc. sells
and distributes sustainable, best-in-class water treatment systems that solve
some of the toughest challenges in the modern water industry. From PFAS capture
and destruction to water reuse technologies, every system delivers on a promise
of uncompromising technical performance, sustainable energy usage and waste
generation metrics, and clear ROI for operations that use them. Its website is www.biolargoequipment.com. BioLargo
Equipment Solutions & Technologies, Inc. is a wholly owned subsidiary of
BioLargo, Inc., a cleantech innovator and environmental engineering solutions
provider dedicated to make life better through technological innovation.
Contact Information
Dennis P. Calvert
President and CEO, BioLargo, Inc.
888-400-2863
Safe Harbor Act
This press release contains forward-looking statements
within the meaning of the Private Securities Litigation Reform Act of 1995.
These forward-looking statements include without limitation those about
BioLargo’s (the “Company”) expectations regarding anticipated revenue; and
plans for future operations. These statements involve risks and uncertainties,
and actual results may differ materially from any future results expressed or
implied by the forward-looking statements. Risks and uncertainties include without
limitation: the effect of regional economic conditions on the Company’s
business, including effects on purchasing decisions by consumers and
businesses; the ability of the Company to compete in markets that are highly
competitive and subject to rapid technological change; the ability of the
Company to manage frequent introductions and transitions of products and
services, including delivering to the marketplace, and stimulating customer
demand for, new products, services, and technological innovations on a timely
basis; the dependency of the Company on the performance of distributors of the
Company’s products. More information on these risks and other potential factors
that could affect the Company’s business and financial results is included in
the Company’s filings with the SEC, including in the “Risk Factors” and
“Management’s Discussion and Analysis of Financial Condition and Results of
Operations” sections of the Company’s most recently filed periodic reports on
Form 10-K and Form 10-Q and subsequent filings. The Company assumes no
obligation to update any forward-looking statements or information, which speak
as of their respective dates.